Hematologic effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patients. [electronic resource]
Producer: 19870707Description: 1654-60 p. digitalISSN:- 0006-4971
- Adult
- Blood Cells -- drug effects
- Combined Modality Therapy
- Female
- Hematopoiesis -- drug effects
- Hemoglobins -- analysis
- Humans
- Immunotherapy
- Interleukin-2 -- therapeutic use
- Killer Cells, Natural -- immunology
- Lymphokines -- pharmacology
- Male
- Middle Aged
- Neoplasms -- blood
- Recombinant Proteins -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.